Osteopontin is upregulated in malignant and inflammatory pleural effusions

Respirology

Volumn 14, Issue 5, 2009, Pages 716-722

  Moschos, Charalampos ^b   Porfiridis, Ilias ^b   Psallidas, Ioannis ^b   Kollintza, Androniki ^b   Stathopoulos, Georgios T ^b   Papiris, Spyros A ^a   Roussos, Charis ^b   Kalomenidis, Ioannis ^a,b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Diagnosis; Malignant pleural effusion; Mesothelioma; Osteopontin; Pleura

Indexed keywords

LACTATE DEHYDROGENASE; OSTEOPONTIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; OSTEOPONTIN; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; PNEUMONIA; PROSPECTIVE STUDIES; TUBERCULOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 68149147209     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01536.x     Document Type: Article

References (34)

1. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev. 2003 14 : 479 88.
2. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell. Biol. 2006 16 : 79 87.
3. Pass HI, Lott D, Lonardo F, Harbut M, Liu Z et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N. Engl. J. Med. 2005 353 : 1564 73.
4. Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M et al. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin. Cancer Res. 2007 13 : 2928 35.
5. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin. Cancer Res. 2001 7 : 4060 66.
6. Donati V, Boldrini L, Dell'Omodarme M, Prati MC, Faviana P et al. Osteopontin expression and prognostic significance in non-small cell lung cancer. Clin. Cancer Res. 2005 11 : 6459 65.
7. Boldrini L, Donati V, Dell'Omodarme M, Prati MC, Faviana P et al. Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer. Br. J. Cancer. 2005 93 : 453 7.
8. Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res. 2002 62 : 3417 27.
9. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000 19 : 615 22.
10. Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K et al. High plasma osteopontin levels in patients with inflammatory bowel disease. J. Clin. Gastroenterol. 2007 41 : 167 72.
11. Kadota J, Mizunoe S, Mito K, Mukae H, Yoshioka S et al. High plasma concentrations of osteopontin in patients with interstitial pneumonia. Respir. Med. 2005 99 : 111 17.
12. Koguchi Y, Kawakami K, Uezu K, Fukushima K, Kon S et al. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am. J. Respir. Crit. Care Med. 2003 167 : 1355 9.
13. Matsui A, Mochida S, Ohno A, Nagoshi S, Hirose T et al. Plasma osteopontin levels in patients with fulminant hepatitis. Hepatol. Res. 2004 29 : 202 6.
14. Tigrani DY, Weydert JA. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations. Am. J. Clin. Pathol. 2007 127 : 580 84.
15. Light WR, MacGregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudations and exudates. Ann. Intern. Med. 1972 77 : 507 14.
16. Light RW. Physiology of the pleural space. In : Light RW (ed.) Pleural Diseases, 4th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2001 8 20.
17. Grove CS, Lee YCG. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr. Opin. Pulm. Med. 2002 8 : 294 301.
18. Elsammak MMY, Morsi TS, Khamis HI, Ragab MS, Zaki MA et al. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion. Ann. Clin. Biochem. 2007 44 : 264 72.
19. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am. J. Pathol. 1996 149 : 293 305.
20. Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 2008 68 : 152 61.
21. Cui R, Takahashi F, Ohashi R, Yoshioka M, Gu T et al. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer. Lung Cancer. 2009 63 : 368 74.
22. Petrik D, Lavori PW, Cao H, Zhu Y, Wong P et al. Plasma osteopontin is an independent prognostic marker for head and neck cancers. J. Clin. Oncol. 2006 24 : 5291 7.
23. Jin JK, Na YJ, Moon C, Kim H, Ahn M et al. Increased expression of osteopontin in the brain with scrapie infection. Brain Res. 2006 1072 : 227 33.
24. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H et al. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukoc. Biol. 2002 72 : 752 61.
25. Patarca R, Saavedra RA, Cantor H. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit. Rev. Immunol. 1993 13 : 225 46.
26. Weber GF, Cantor H. The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev. 1996 7 : 241 8.
27. Vordermark D, Said HM, Katzer A, Kuhnt T, Hänsgen G et al. Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system. BMC Cancer. 2006 6 : 207.
28. Singh M, Ananthula S, Milhorn DM, Krishnaswamy G, Singh K. Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front. Biosci. 2007 12 : 214 21.
29. Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP et al. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur. Heart J. 2006 27 : 802 7.
30. Coskun S, Atalar E, Ozturk E, Yavuz B, Ozer N et al. Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes. J. Natl. Med. Assoc. 2006 98 : 1746 50.
31. Stawowy P, Blaschke F, Pfautsch P, Goetze S, Lippek F et al. Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur. J. Heart Fail. 2002 4 : 139 46.
32. Xie Z, Singh M, Singh K. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 44 : 826 31.
33. Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am. J. Roentgenol. 1990 154 : 487 92.
34. Rodriguez-Panadero F. Effusions from malignancy. In : Light RW, Lee YCG (eds) Textbook of Pleural Diseases, 2nd edn. Hodder Arnold, London, 2008 323 40.